US Stock MarketDetailed Quotes
BCAB BioAtla
- 2.200
- -0.150-6.38%
Close Oct 4 16:00 ET
- 2.219
- +0.019+0.85%
Post 19:34 ET
106.34MMarket Cap-1013P/E (TTM)
2.400High2.110Low2.19MVolume2.330Open2.350Pre Close4.89MTurnover5.87%Turnover RatioLossP/E (Static)48.34MShares4.02052wk High3.39P/B82.09MFloat Cap1.14052wk Low--Dividend TTM37.31MShs Float76.630Historical High--Div YieldTTM12.34%Amplitude1.140Historical Low2.232Avg Price1Lot Size
BioAtla Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 20.34%-19.19M | -36.08%-30.83M | -15.04%-104.02M | -22.90%-29.92M | -13.86%-27.35M | -42.39%-24.09M | 9.87%-22.65M | -45.34%-90.42M | -16.22%-24.35M | -88.72%-24.02M |
| Net income from continuing operations | 41.06%-21.07M | 15.39%-23.23M | -15.95%-123.46M | 2.24%-26.93M | -29.27%-33.33M | -23.68%-35.75M | -13.22%-27.46M | -11.61%-106.48M | -17.76%-27.54M | -12.42%-25.78M |
| Operating gains losses | ---- | ---- | -84.62%2K | ---- | ---- | ---- | ---- | 101.90%13K | --7K | --0 |
| Depreciation and amortization | -21.03%229K | -18.09%240K | 1.83%1.22M | 23.49%368K | -10.00%270K | 0.69%290K | -6.39%293K | -9.85%1.2M | -5.10%298K | -21.05%300K |
| Change In working capital | -111.00%-846K | -1,227.25%-10.13M | 1,530.66%4.68M | -900.82%-6.11M | 203.20%2.19M | -1.99%7.69M | 118.62%899K | -96.13%287K | 63.76%-610K | -134.56%-2.13M |
| -Change in prepaid assets | 168.75%1.12M | 59.16%-860K | 99.58%-11K | 388.30%1.29M | 237.01%385K | 231.23%416K | 7.55%-2.11M | -1,001.69%-2.61M | -79.28%265K | -124.87%-281K |
| -Change in payables and accrued expense | -126.21%-1.95M | -384.93%-8.98M | 54.91%5.28M | -886.26%-7.25M | 214.97%1.96M | -10.36%7.42M | 229.51%3.15M | -57.32%3.41M | 74.23%-735K | -133.21%-1.7M |
| -Change in other working capital | 87.76%-18K | -102.74%-296K | -15.59%-593K | -7.14%-150K | -6.38%-150K | -26.72%-147K | -25.86%-146K | -54.98%-513K | -27.27%-140K | -28.18%-141K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 20.34%-19.19M | -36.08%-30.83M | -15.04%-104.02M | -22.90%-29.92M | -13.86%-27.35M | -42.39%-24.09M | 9.87%-22.65M | -45.34%-90.42M | -16.22%-24.35M | -88.72%-24.02M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 63.02%-98K | 74.19%-8K | 56.90%-25K | 90.96%-15K | -400.00%-50K | 71.32%-265K | 65.17%-31K | 41.41%-58K |
| Net PPE purchase and sale | --0 | --0 | 63.02%-98K | 74.19%-8K | 56.90%-25K | 90.96%-15K | -400.00%-50K | 71.32%-265K | 65.17%-31K | 41.41%-58K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 63.02%-98K | 74.19%-8K | 56.90%-25K | 90.96%-15K | -400.00%-50K | 71.32%-265K | 65.17%-31K | 41.41%-58K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 95.65%225K | 88.79%-13K | -99.87%77K | -99.81%119K | 57.29%-41K | 325.49%115K | 71.36%-116K | -11.94%61.21M | 1,680.48%61.77M | -100.13%-96K |
| Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -13.12%61.68M | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | 16.26%336K | -44.81%149K | --14K | ---- | ---- | -32.63%289K | 172.73%270K | --0 |
| Net other financing activities | 67.24%-19K | 88.79%-13K | 65.83%-259K | 83.96%-30K | 42.71%-55K | 17.14%-58K | 71.36%-116K | 60.33%-758K | ---187K | ---96K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 95.65%225K | 88.79%-13K | -99.87%77K | -99.81%119K | 57.29%-41K | 325.49%115K | 71.36%-116K | -11.94%61.21M | 1,680.48%61.77M | -100.13%-96K |
| Net cash flow | ||||||||||
| Beginning cash position | -58.15%80.63M | -48.27%111.47M | -12.03%215.51M | -20.68%141.28M | -16.61%168.69M | -12.19%192.69M | -12.03%215.51M | 2.67%244.98M | -34.01%178.12M | -2.56%202.29M |
| Current changes in cash | 20.95%-18.97M | -35.15%-30.84M | -253.00%-104.04M | -179.74%-29.81M | -13.41%-27.41M | -40.00%-23.99M | 10.69%-22.82M | -562.38%-29.47M | 249.87%37.39M | -138.79%-24.17M |
| End cash Position | -63.45%61.66M | -58.15%80.63M | -48.27%111.47M | -48.27%111.47M | -20.68%141.28M | -16.61%168.69M | -12.19%192.69M | -12.03%215.51M | -12.03%215.51M | -34.01%178.12M |
| Free cash flow | 20.39%-19.19M | -35.78%-30.83M | -14.80%-104.11M | -22.77%-29.93M | -13.69%-27.37M | -41.07%-24.11M | 9.71%-22.7M | -43.63%-90.69M | -15.88%-24.38M | -87.71%-24.07M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
